Debate article: Management of breast cancer in patients with pre-existing bilateral breast augmentation-a snapshot of global practice and call for international guidelines.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
13 Aug 2024
Historique:
received: 04 11 2023
revised: 06 05 2024
accepted: 14 06 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 18 8 2024
Statut: aheadofprint

Résumé

Breast cancer (BC) is the most common female cancer, and as bilateral breast augmentation (BBA) increases, more women are presenting with BC within an augmented breast. No international guidelines exist on how to manage such a situation, so this group undertook a global survey to provide a snapshot of current surgical practice. The key finding was the variable oncoplastic management of BC after BBA: most surgeons responded that when oncologically safe, breast conservation with implant preservation was appropriate as radiotherapy was not a contra-indication to preserving implants. Immediate symmetrisation could be considered but was not always available. We propose a large multicenter observational study to support the development of international guidelines. This will help patients, healthcare funders, providers, and surgeons to optimize care and reduce inequity of access to appropriate oncoplastic surgery options for the increasing number of women with BBA and BC.

Identifiants

pubmed: 39154429
pii: S0748-7983(24)00658-9
doi: 10.1016/j.ejso.2024.108606
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108606

Informations de copyright

Copyright © 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

Sue Down (S)

Department of Breast Surgery, James Paget University Hospital, Great Yarmouth UK and School of Medicine, University of East Anglia, Norwich, UK. Electronic address: sue.down@jpaget.nhs.uk.

Kerstin Sandelin (K)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Lynda Wyld (L)

Department of Clinical Medicine, University of Sheffield, Sheffield, UK and Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, UK.

Fiona MacNeill (F)

The London Breast Clinic, London, UK.

Riccardo Audisio (R)

Sahlgrenska Academy, University of Gothenburg, Sweden.

Classifications MeSH